Related references
Note: Only part of the references are listed.Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
David E. Neal et al.
EUROPEAN UROLOGY (2020)
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review
Michael Lardas et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years
Daniel A. Barocas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review
Penny F. Whiting et al.
BJU INTERNATIONAL (2016)
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment
Leonard P. Bokhorst et al.
EUROPEAN UROLOGY (2016)
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
J. L. Donovan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy
Claudio Jeldres et al.
CANCER (2015)
Patient and disease factors affecting the choice and adherence to active surveillance
Marc A. Dall'Era
CURRENT OPINION IN UROLOGY (2015)
How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review
Lara Bellardita et al.
EUROPEAN UROLOGY (2015)
Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers
Leonard P. Bokhorst et al.
EUROPEAN UROLOGY (2015)
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance
Sam Watts et al.
BMJ OPEN (2015)
A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels
Lionne D. F. Venderbos et al.
PSYCHO-ONCOLOGY (2015)
A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer
Sanoj Punnen et al.
BJU INTERNATIONAL (2013)
Active Surveillance, Quality of Life, and Cancer-related Anxiety
Laurence Klotz
EUROPEAN UROLOGY (2013)
Medium-term Outcomes of Active Surveillance for Localised Prostate Cancer
Elizabeth D. Selvadurai et al.
EUROPEAN UROLOGY (2013)
Predictors of Health-related Quality of Life and Adjustment to Prostate Cancer During Active Surveillance
Lara Bellardita et al.
EUROPEAN UROLOGY (2013)
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
Meelan Bul et al.
EUROPEAN UROLOGY (2013)
Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial
Hanna Vasarainen et al.
BJU INTERNATIONAL (2012)
Psychological aspects of active surveillance
Roderick C. N. van den Bergh et al.
CURRENT OPINION IN UROLOGY (2012)
Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden
Melissa S. Y. Thong et al.
BJU INTERNATIONAL (2010)
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study
Roderick C. N. van den Bergh et al.
BJU INTERNATIONAL (2010)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance
David M. Latini et al.
JOURNAL OF UROLOGY (2007)